Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2025-12-25 @ 1:47 AM
NCT ID:
NCT01572194
Eligibility Criteria:
Inclusion Criteria:
* Bearer of lung transplantation (single or double lung, with or without associated cardiac transplantation)
* Suffering from cystic fibrosis
* Aged 18 and over
* With at least 6 months of transplantation
* Having a glomerular filtration rate measured by technical radionuclide \> 30 ml / min
* Having given written consent to the study Patients meeting these criteria will enter in the "organic" in the study (determination of PIIINP urinary)
Exclusion Criteria:
* Lung transplantation for a condition other than cystic fibrosis
* Patient refused follow-up
* Patients with advanced liver disease (conditions that interfere with the assay of PIIINP)
* Minor
* Pregnant women,
* Major Trust, benefiting from a regime of legal protection (guardianship, trusteeship, safeguarding justice.
* Patient unable to grant informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01572194
Study Brief:
Protocol Section:
NCT01572194